The revenue of Indraprastha Gas zoomed 18.11% for the quarter ended September 2013 compared to the same period last year. However, the Net Profit registered a slight decline of 6.51%. Glaxo Consumer Healthcare witnessed an 18.23% growth in revenue but Net Profit grew only 14.3% for the quarter. BHEL's sales declined 14.93% for the quarter while Net Profit fell sharply by 64.22% compared to the corresponding quarter of the previous year. Operating profit also decreased for BHEL.

1. Results Tracker
Thursday,07 November 2013
make more, for sure.
Q2FY14
Results to be Declared on 7th November 2013
COMPANIES NAME
Aarya Global Shares
Allsec Tech
DLINK IND
Eicher Motors
ITI
JJ Finance
Prestige Estates
Prime Cap
Tourism Fin Corp
TPL Plastech
Arvind Remedies
Asian Tea
ATV Projects
Aurobindo Phar
Bengal Steel
Glodyne Tech
Godavari Drugs
Gokak Textiles
Goodricke Group
Hinduja Found
Kabra Extr
KBS INDIA
Lakhotia Poly
Lakshmi Auto Loom
Loyal Textile
Radico Khaitan
Rajdhani Leas
Redington India
Riverdale Foods
Rossell India
TRF
Triveni Engr
TV Today
TVS Electronics
Unisys Soft
Bhagiradha Che
Hinduja Vent
Mahavir Adv
Sarthak Global
United Brew
Capital Trust
Caplin Point
Century Extr
Chennai Petro
CNI Research
HSIL
ICDS
India Cements
Indian Extr
Indsil Hydro
Mardia Samyoung
Marigold Glass
MM Forgings
Modella Wool
MOIL
Senbo Inds
Setco Auto
Shalimar Wires
Shreyans Inds
Spicejet
Universal Prime
VA Tech Wabag
VCCL
Vimta Labs
Warner Multi
Control Print
Cosmo Ferrites
Cummins India
Ingersoll Rand
Intec Cap
Intl Data Mgmt
Nagarjuna Oil Ref
Network
PCS Technology
Stewarts & Lloyds
Suryalakshmi
Tata Coffee
Yash Management
Disa India
ITD Cem India
Plastiblends
Tech Mahindra
Results Announced on 06th November 2013 (Rs Million)
Indraprastha Gas
Sales
Other Income
PBIDT
Interest
PBDT
Depreciation
PBT
TAX
Deferred Tax
PAT
Equity
PBIDTM(%)
Quarter ended
201309
10100.3
38.4
1501.8
98.1
1403.7
0
1403.7
476.2
0
927.5
1400
14.87
201209
8551.9
33.07
2098.91
140.33
1958.58
477.03
1481.55
489.42
0
992.13
1400
24.54
% Var
18.11
16.12
-28.45
-30.09
-28.33
0
-5.25
-2.7
0
-6.51
0
-39.42
Year to Date
201309
19127.3
76.5
3479.1
226.1
3253
531.5
2721.5
918.2
0
1803.3
1400
18.19
201209
16158.7
64.47
3927.61
295.53
3632.08
903.83
2728.25
885.62
0
1842.63
1400
24.31
% Var
18.37
18.66
-11.42
-23.49
-10.44
-41.19
-0.25
3.68
0
-2.13
0
-25.17
Year ended
201303
33669.99
128.96
7710.38
561.93
7148.45
1866.58
5281.87
1740.62
0
3541.25
1400
22.9
201203
25178.36
75.12
6411.74
478.84
5932.9
1431.98
4500.92
1436.6
0
3064.32
1400
25.47
% Var
33.73
71.67
20.25
17.35
20.49
30.35
17.35
21.16
0
15.56
0
-10.07
he revenue zoomed 18.11% to Rs. 10100.30 millions for the quarter ended September 2013 as compared to Rs. 8551.90 millions during
he corresponding quarter last year.The Net Profit of the company registered a slight decline of -6.51% to Rs. 927.50 millions from Rs.
92.13 millions.Operating profit for the quarter ended September 2013 decreased to 1501.80 millions as compared to 2098.91 millions of
corresponding quarter ended September 2012.
Please refer to important disclosures at the end of this report
For Private circulation Only
Mansukh Securities and Finance Ltd
Office: 306, Pratap Bhavan, 5, Bahadur Shah Zafar Marg, New Delhi-110002
Phone: 011-30123450/1/3/5 Fax: 011-30117710 Email: research@moneysukh.com
Website: www.moneysukh.com
For Our Clients Only
SEBI Regn No. BSE: INB010985834 /
NSE: INB230781431
PMS Regn No. INP000002387

2. Results Tracker
Q2FY14
make more, for sure.
Results Announced on 06th November 2013 (Rs Million)
Glaxo.Cons. Health
Sales
Quarter ended
201309
201209
10140.8
8577
% Var
18.23
Year to Date
201309
28797.6
201209
24525.4
% Var
17.42
Year ended
201212
31875
201112
27650.1
% Var
15.28
Other Income
PBIDT
Interest
PBDT
Depreciation
PBT
TAX
Deferred Tax
PAT
433.9
2238.4
1.4
2237
0
2237
767.7
0
1469.3
276.1
1982.5
2.7
1979.8
77
1902.8
617.3
0
1285.5
57.15
12.91
-48.15
12.99
0
17.56
24.36
0
14.3
1143.6
6571.5
4.4
6567.1
229
6338.1
2105.1
0
4233
806
5756.8
22.8
5734
281.7
5452.3
1781.1
0
3671.2
41.89
14.15
-80.7
14.53
-18.71
16.25
18.19
0
15.3
1137.9
7172
24.2
7147.8
360.8
6787
2119.3
0
4667.7
852.5
5897.1
34.7
5862.4
459.8
5402.6
1850.5
0
3552.1
33.48
21.62
-30.26
21.93
-21.53
25.62
14.53
0
31.41
Equity
420.6
420.6
0
420.6
420.6
0
420.6
420.6
0
PBIDTM(%)
22.07
23.11
-4.5
22.82
23.47
-2.78
22.5
21.33
5.5
The company witnessed a 18.23% growth in the revenue at Rs. 10140.80 millions for the quarter ended September 2013 as compared to
? s. 8577.00 millions during the year-ago period.A slim rise of 14.30% was recorded in the Net profit for the quarter ended September 2013
to Rs. 1469.30 millions From Rs. 1285.50 millions.OP of the company witnessed a marginal growth to 2238.40 millions from 1982.50
millions in the same quarter last year.
BHEL
Quarter ended
201309
201209
Sales
Other Income
PBIDT
Interest
PBDT
Depreciation
PBT
TAX
Deferred Tax
PAT
89843.5
4979
9098.3
246.6
8851.7
2386.8
6464.9
1905.4
0
4559.5
105615.5
1306.7
20301.4
258.6
20042.8
2163.1
17879.7
5135.2
0
12744.5
Equity
PBIDTM(%)
4895.2
9.6
4895.2
18.17
Year to Date
201309
201209
281.04
-55.18
-4.64
-55.84
10.34
-63.84
-62.9
0
-64.22
154424.7
10363.8
18368.9
524.2
17844.7
4694.8
13149.9
3936.1
0
9213.8
190005.6
4969.4
35986
313.8
35672.2
4447
31225.2
9271.7
0
21953.5
0
-47.19
4895.2
11.9
4895.2
18.94
% Var
-14.93
Year ended
201303
201203
108.55
-48.96
67.05
-49.98
5.57
-57.89
-57.55
0
-58.03
484246.5
11217.1
105111
1252.7
103858.3
9533.9
94324.4
28177.1
0
66147.3
479788.9
12655.5
111535.4
512.8
111022.6
8000
103022.6
32623
0
70399.6
0
-37.19
4895.2
20.62
4895.2
22.19
% Var
-18.73
% Var
0.93
-11.37
-5.76
144.29
-6.45
19.17
-8.44
-13.63
0
-6.04
0
-7.06
The sales declined to Rs. 89843.50 millions for the September 2013 quarter as compared to Rs. 105615.50 millions during the
corresponding quarter last year.Net profit of the cmpany stood at Rs. 4559.50 millions for the quarter ended September 2013 a decline of 64.22% from Rs. 12744.50 millions in the same quarter last year.The Operating Profit of the company witnessed a decrease to 9098.30
millions from 20301.40 millions.
Please refer to important disclosures at the end of this report
For Private circulation Only
Mansukh Securities and Finance Ltd
Office: 306, Pratap Bhavan, 5, Bahadur Shah Zafar Marg, New Delhi-110002
Phone: 011-30123450/1/3/5 Fax: 011-30117710 Email: research@moneysukh.com
Website: www.moneysukh.com
For Our Clients Only
SEBI Regn No. BSE: INB010985834 /
NSE: INB230781431
PMS Regn No. INP000002387

3. Results Tracker
Q2FY14
make more, for sure.
Data Source : ACE Equity
NAME
DESIGNATION
E-MAIL
Varun Gupta
Head - Research
varungupta@moneysukh.com
Mohit Taneja
Research Analyst
mohit.t@moneysukh.com
This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you.
Mansukh Securities and Finance Ltd (hereinafter referred as MSFL) is not soliciting any action based on it. This report is not for public distribution and
has been furnished to you solely for your information and should not be reproduced or redistributed to any person in any form.
The report is based upon information that we consider reliable, but we do not represent that it is accurate or complete. MSFL or any of its affiliates or
employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information
contained in this report. MSFL or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding
any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and noninfringement. The recipients of this report should rely on their own investigations.
MSFL and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. This
information is subject to change without any prior notice. MSFL reserves the right to make modifications and alterations to this statement as may be
required from time to time. Nevertheless, MSFL is committed to providing independent and transparent recommendations to its clients, and would be
happy to provide information in response to specific client queries.
Please refer to important disclosures at the end of this report
For Private circulation Only
Mansukh Securities and Finance Ltd
Office: 306, Pratap Bhavan, 5, Bahadur Shah Zafar Marg, New Delhi-110002
Phone: 011-30123450/1/3/5 Fax: 011-30117710 Email: research@moneysukh.com
Website: www.moneysukh.com
For Our Clients Only
SEBI Regn No. BSE: INB010985834 /
NSE: INB230781431
PMS Regn No. INP000002387